Emerging therapeutics based on gene addition, editing, or silencing are expected to change the landscape of genetic liver disease.Watch this episode to find out:Which approaches exist?Where are they in terms of preclinical and clinical development?How will they be used?FacultyDr Mattias Mandorfer (Moderator)Dr Gloria Gonzalez-Aseguinolaza (Faculty)Prof. Pavel Strnad (Faculty)Prof. Man-Fung Yuen (Faculty)All EASL Studio Podcasts are available on EASL Campus.